CureVac was founded in 2000 and is headquartered in Tübingen, DE
Report incorrect company information
Key People/Management at CureVac
Ingmar Hoerr
Chairman of the Executive Board / Chief Executive Officer / President of CureVac Inc
Florian von der Mulbe PhD, MBA
COO
Mariola Fotin-Mleczek
Chief Scientific Officer
BA Daniel L. Menichella MBA
Chief Business Officer of CureVac AG / Chief Executive Officer of CureVac Inc. (USA)
LLD Franz-Werner Haas LLM
Chief Corporate Officer
Ulrike Gnad-Vogt
Chief Medical Officer
Report incorrect company information
CureVac Office Locations
CureVac has offices in Boston, Frankfurt am Main and Tübingen
Tübingen, DE (HQ)
Paul-Ehrlich-Str. 15
Frankfurt am Main, DE
27 Schumannstraße
Tübingen, DE
15 Paul-Ehrlich-Straße
Boston, US
51 Melcher St
Report incorrect company information
CureVac Financials and Metrics
Summary Metrics
Founding Date | 2000 |
Total Funding | $359 m |
Latest funding size | $29.50 m |
Time since last funding | 2 years ago |
Investors | Bill & Melinda Gates Foundation, DH Capital, dievini Hopp Biotech Holding, OH Beteiligungen, Sigma Group, Baillie Gifford, LBBW Asset Management, Northview LifeSciences, Chartwave, Landeskreditbank Baden-Württemberg, Baden-Württembergische Versorgungsanstalt für Ärzte, Coppel Family |
CureVac's latest funding round in November 2016 was reported to be $29.5 m. In total, CureVac has raised $359 m. CureVac's latest valuation is reported to be $1.7 b.
CureVac Financials
Market valuation | 1.7 b |
Report incorrect company information
CureVac News and Updates
June 19, 2017
Pharma’s Future: 100+ Startups Working Across Alzheimer’s, Diabetes, Cancer, And More
The pharmaceutical industry is changing at a rapid pace. The introduction of immunotherapy techniques such as CAR-T cell therapy and cancer vaccines are bringing oncology into the 21st century while CRISPR is poised to bring genetic editing into every clinic … Continued
Report incorrect company information